Literature DB >> 11720663

Clinical relevance of internal mammary node mapping as a guide to radiation therapy.

E L Dupont1, C J Salud, E S Peltz, K Nguyen, G F Whitehead, N N Ku, D S Reintgen, C E Cox.   

Abstract

BACKGROUND: The surgical management of breast cancer has changed markedly with the development of lymphatic mapping and sentinel lymph node (SLN) biopsy. Lymphatic mapping technique varies with respect to injection method, mapping agent, and surgical technique. The decision to pursue the internal mammary nodes (IMN) is another source of controversy.
METHODS: From April 1998 to November 2000, 1,470 patients underwent lymphatic mapping for breast cancer and were prospectively entered into the breast database. The combined technique method was used, consisting of both isosulfan blue dye and technetium-99 labeled sulfur colloid. Patients with inner quadrant lesions and suspicion for internal mammary metastasis had preoperative lymphoscintigraphy. Those with internal mammary radioactivity noted by either lymphoscintigraphy or gamma probe underwent removal of the internal mammary sentinel nodes.
RESULTS: Thirty-six of the 1,470 (2.4%) patients mapped had at least 1 internal mammary lymph node removed. Inner quadrant lesions were present in 24 of the 36 (67%) IMN mapped patients. Of the 36 patients mapping to the IM area, 5 (14%) had at least 1 IM node positive. Two of the 5 (40%) had only IM metastasis, with 1 of these patients having 5 of 5 IMN positive and no disease detected in her axilla. A total of 2 of the 5 (40%) IM positive patients had more than 1 IMN positive. Twenty-eight of the 36 (78%) IM node harvested patients had preoperative lymphoscintigraphy, with 18 (64%) IMN appearing on imaging. Complications occurred in 3 of the 36 (8%) IMN mapped patients, without clinical significance.
CONCLUSIONS: Mapping to the IMN basin with the finding of metastasis results in N3 disease by the current staging system. The consequence for these patients is radiation therapy to the IMN basin. It is significant to note that 14% (5 of 36) were upstaged as result of IMN detection and 40% (2 of 5) had multiple positive IMNs. Substantial disease was detected in these 5 patients necessitating additional radiation therapy while avoiding IM radiation and its attendant complications in 86% of patients mapping to the IM basin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11720663     DOI: 10.1016/s0002-9610(01)00720-6

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  5 in total

1.  [Sentinel lymph node biopsy in breast cancer].

Authors:  A Rody; C Solbach; M Kaufmann
Journal:  Chirurg       Date:  2004-08       Impact factor: 0.955

2.  Sentinel lymphnode biopsy in early breast cancer using methylene blue dye and radioactive sulphur colloid - a single institution Indian experience.

Authors:  S P Somashekhar; S Zaveri Shabber; K Udupa Venkatesh; K Venkatachala; M M Vasan Thirumalai
Journal:  Indian J Surg       Date:  2008-07-24       Impact factor: 0.656

3.  The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer.

Authors:  Eve Madsen; Pd Gobardhan; V Bongers; M Albregts; Jpj Burgmans; P De Hooge; J Van Gorp; Th van Dalen
Journal:  Ann Surg Oncol       Date:  2007-01-26       Impact factor: 5.344

4.  Validation study for the hypothesis of internal mammary sentinel lymph node lymphatic drainage in breast cancer.

Authors:  Bin-Bin Cong; Peng-Fei Qiu; Yan-Bing Liu; Tong Zhao; Peng Chen; Xiao-Shan Cao; Chun-Jian Wang; Zhao-Peng Zhang; Xiao Sun; Jin-Ming Yu; Yong-Sheng Wang
Journal:  Oncotarget       Date:  2016-07-05

Review 5.  Will early detection of non-axillary sentinel nodes affect treatment decisions?

Authors:  F Wärnberg; N Bundred
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.